Bajo M Auxiliadora, Del Peso Gloria, Teitelbaum Isaac
Home Dialysis Unit, Nephrology Department, La Paz University Hospital, Madrid, Spain.
University Autónoma of Madrid, Hospital La Paz Institute for Health Research, Spanish Renal Research Network, Reina Sofia Institute for Nephrology Research, Madrid, Spain.
Semin Nephrol. 2017 Jan;37(1):77-92. doi: 10.1016/j.semnephrol.2016.10.009.
Peritoneal dialysis (PD) is a successfully used method for renal replacement therapy. However, long-term PD may be associated with peritoneal fibrosis and ultrafiltration failure. The key factors linked to their appearance are repeated episodes of inflammation associated with peritonitis and long-term exposure to bioincompatible PD fluids. Different strategies have been proposed to preserve the peritoneal membrane. This article reviews the functional and structural alterations related to PD and strategies whereby we may prevent them to preserve the peritoneal membrane. The use of new, more biocompatible, PD solutions is promising, although further morphologic studies in patients using these solutions are needed. Blockade of the renin-angiotensin-aldosterone system appears to be efficacious and strongly should be considered. Other agents have been proven in experimental studies, but most of them have not yet been tested appropriately in human beings.
腹膜透析(PD)是一种成功应用于肾脏替代治疗的方法。然而,长期腹膜透析可能与腹膜纤维化和超滤失败有关。与它们出现相关的关键因素是与腹膜炎相关的反复炎症发作以及长期接触生物不相容的腹膜透析液。已经提出了不同的策略来保护腹膜。本文综述了与腹膜透析相关的功能和结构改变以及我们可以预防这些改变以保护腹膜的策略。使用新型、生物相容性更好的腹膜透析液是有前景的,尽管需要对使用这些溶液的患者进行进一步的形态学研究。阻断肾素-血管紧张素-醛固酮系统似乎是有效的,强烈建议考虑。其他药物在实验研究中已得到证实,但其中大多数尚未在人体中进行适当测试。